PetMed Express, Inc.
PetMed Express, Inc. (PETS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PETS · as of Jun 15, 2026
Key Statistics
Explore PetMed Express, Inc. Data
pets stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 20.0%
The PETS analyst consensus is Hold, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +547.06% upside from the current price of $1.70.
Competitors & Peers
pets competitorsPETS
BDSX
CTSO
FBIO
GNTA
ICCMStock Performance
Full HistoryAbout PetMed Express, Inc.
PetMed Express, Inc. through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counte…
what is petmed express, inc. · pets stock overview · petmed express, inc. company profile · who is petmed express, inc. ceo · pets NASDAQ · petmed express, inc. headquarters · petmed express, inc. business segments
About Stock Overview & Key Data
PetMed Express, Inc. (PETS) is a Healthcare company in the Medical - Pharmaceuticals industry, listed on NASDAQ since Apr 26, 1999. As of the latest trading session, PETS stock price is $1.70, with a market capitalization of $39.5M. The stock has returned -48.61% over the past 12 months and -42.19% year-to-date.
According to 10 Wall Street analysts, the consensus rating for PetMed Express, Inc. stock is Hold, with an average 12-month price target of $11.00. In fiscal year 2026, PetMed Express, Inc. reported revenue of $179.0M and net income of -$57.3M. For detailed data — including PetMed Express, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PetMed Express, Inc. (PETS) stock price is $1.70. The stock is traded on NASDAQ under the ticker symbol PETS. The 52-week range is $1.57 – $4.10.